Skip to content

Semilente Insulin, Serum/Plasma — Mass Concentration

Published: August 9, 2026Updated: August 16, 2026

A blood test that measures semilente insulin, an older intermediate-acting insulin formulation; timing after a dose is important for interpretation.

Quick summary

["This test measures the amount of semilente insulin in blood, with results interpreted according to dose and collection timing."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
4288-7
Short code
Insulin Semilente Dose
Synonyms
Insulin Semilente Dose
Category
hormone
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Ref low
2.6
Ref high
24.9
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
83525
SNOMED
413618004
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What is this test?

This test measures the concentration of semilente insulin in serum or plasma. Semilente is an older intermediate-acting insulin preparation, and the result may reflect insulin administered as a specified dose.

Why might I need this test?

A clinician may order this test to evaluate insulin levels, assess glucose regulation, or follow the response to semilente insulin. It may also help distinguish insulin produced by the body from certain insulin preparations.

How is the test performed?

A blood sample is drawn and analyzed in the laboratory to determine the insulin concentration. The laboratory may use an immunoassay or another validated method.

How do I prepare for the test?

Follow the laboratory and prescribing clinician's instructions about fasting and timing. If you take semilente insulin, record the dose and exact time of the injection, because the blood sample is often collected at a specific interval after the dose.

Reference range

Fasting: 2.6-24.9 μIU/mLN/A

Specimen: serum

No special preparation usually required. Stay well hydrated. Inform your healthcare provider of all medications and supplements you are taking.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Higher insulin values can occur after an insulin dose, with insulin resistance, or in conditions involving excess insulin production. Lower values may occur when insulin is not being produced adequately or when the measured level does not reflect the administered formulation. Results should be interpreted with blood glucose, symptoms, medication timing, and other relevant tests rather than used alone to diagnose a condition.

Short name

Semilente insulin level

Frequently asked questions

What is semilente insulin?
Semilente is an older intermediate-acting insulin preparation. It is different from rapid-acting and long-acting insulin formulations.
Why is the timing of the blood draw important?
Insulin levels change after a dose, so the result is meaningful only when the collection time is compared with the dose and administration time.
Does this test alone diagnose diabetes?
No. A clinician interprets the insulin level together with blood glucose, symptoms, medication use, and other laboratory findings.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy